Aromatherapy Versus Diet

Aromatherapy Versus Diet Management on Children with Primary Nocturnal Enuresis

Eligible children were randomly divided into 2 groups assigned to receive dietary recommendations (group A) or to receive herbal compounds (group B). Children were treated for a period of one week , then cross over the two groups is done

Study Overview

• Status: Not yet recruiting
• Conditions: Nocturnal Enuresis
• Intervention / Treatment: Behavioral: dietary recommendations; Other: aroma therapy

• Study Type: Interventional
• Enrollment (Estimated): 30
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• The participants age will be ranged from 5to 10 years.
• primary Nocturnal enuresis(NE) number of wet nights/week is more than 4\7

Exclusion Criteria:

• secondary nocturnal enuresis to any neurological disorders , musculoskeletal problems, or congenital abnormalities
• the child receives any Pharmacological treatment to NE

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: group A; Children were receive dietary recommendations or nonspecific dietary advices such as reducing fluid intake after 6 p.m. The list of dietary advices have been made reviewing literature and consisted in a list of recommended food, not recommended food at evening and not recommended food	Behavioral: dietary recommendations; . receive dietary recommendations or nonspecific dietary advices such as reducing fluid intake after 6 p.m. The list of dietary advices have been made reviewing literature and consisted in a list of recommended food, not recommended food at evening and not recommended food; Other: aroma therapy; the case receive aroma therapy
Experimental: Group B; GROUP B receive Harpal product	Behavioral: dietary recommendations; . receive dietary recommendations or nonspecific dietary advices such as reducing fluid intake after 6 p.m. The list of dietary advices have been made reviewing literature and consisted in a list of recommended food, not recommended food at evening and not recommended food; Other: aroma therapy; the case receive aroma therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
number of wet days per week	for baseline evaluation of number of wet days per week, if the number is less than 4\7 the child will be excluded from the study.	; for baseline evaluation of number of wet days per week, if the number is less than 4\7 the child will be excluded from the study. Second week; group A receives dietary recommendations , group B receives herbal compounds

Collaborators and Investigators

• Sponsor: Cairo University

Study record dates

Study Major Dates

• Study Start (Estimated): March 5, 2025
• Primary Completion (Estimated): May 5, 2025
• Study Completion (Estimated): May 10, 2025

Study Registration Dates

• First Submitted: February 27, 2025
• First Submitted That Met QC Criteria: February 27, 2025
• First Posted (Actual): March 25, 2025

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: February 27, 2025
• Last Verified: February 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Urogenital Diseases; Mental Disorders; Male Urogenital Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urination Disorders; Lower Urinary Tract Symptoms; Urological Manifestations; Behavioral Symptoms; Elimination Disorders; Urinary Incontinence; Enuresis; Nocturnal Enuresis
• Other Study ID Numbers: aromatherapy versus diet

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No